CD95/Fas protects triple negative breast cancer from anti-tumor activity of NK cells.
Qadir AS, Guégan JP, Ginestier C, Chaibi A, Bessede A, Charafe-Jauffret E, Macario M, Lavoué V, Rouge TM, Law C, Vilker J, Wang H, Stroup E, Schipma MJ, Bridgeman B, Murmann AE, Ji Z, Legembre P, Peter ME.
Qadir AS, et al.
iScience. 2021 Oct 29;24(11):103348. doi: 10.1016/j.isci.2021.103348. eCollection 2021 Nov 19.
iScience. 2021.
PMID: 34816102
Free PMC article.